(Q44132929)

30 November 2017

title

Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine (English)

1 reference

randomized controlled trial

30 November 2017

1 reference

1 reference

1 reference

Briant E Burke

1

1 reference

30 November 2017

Richard D Olson

series ordinal

2

1 reference

30 November 2017

Barry J Cusack

series ordinal

3

1 reference

30 November 2017

publication date

1 August 2002

1 reference

Biomedicine and Pharmacotherapy

30 November 2017

published in

1 reference

30 November 2017

volume

56

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

283-288

1 reference

30 November 2017

cites work

Epidemiology of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Effect of Japanese Angelica root and peony root on uterine contraction in the rabbit in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Propranolol in the management of recurrent migraine: a meta-analytic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Relationship of headache to phase of the menstrual cycle among young women: a daily diary study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Introduction to sample size determination and power analysis for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Diagnosis and epidemiology of pediatric migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Differential estrogen receptor binding of estrogenic substances: a species comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Predictability of exogenous hormone effect on subgroups of migraineurs

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Estrogens, progestins, and headache

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Sex hormones and headache

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Menstrual cycle and headache in a population sample of migraineurs

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Physiology of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Spinal cord infarction during use of zolmitriptan: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

Soy isoflavones: are they useful in menopause?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900181-6

7 January 2021

10.1016/S0753-3322(02)00181-6

Identifiers

DOI

1 reference

30 November 2017

1 reference